Skip to product information
1 of 1

BRIP1 Recombinant Rabbit mAb (S-4535-79)

BRIP1 Recombinant Rabbit mAb (S-4535-79)

Catalog Number: S0B60459 Application: WB Reactivity: Hu Conjugation: Unconjugated Brand: Starter
Price:
Regular price $100 USD
Regular price Sale price $100 USD
Size:

For shipping services or bulk orders, you may request a quotation.
Secure checkout with
View full details

Product Details

Product Specification


Host Rabbit
Antigen BRIP1
Synonyms Fanconi anemia group J protein; BRCA1-associated C-terminal helicase 1; BRCA1-interacting protein C-terminal helicase 1 (BRCA1-interacting protein 1); DNA 5'-3' helicase FANCJ; BACH1; FANCJ
Immunogen Synthetic Peptide
Location Cytoplasm, Nucleus
Accession Q9BX63
Clone Number S-4535-79
Antibody Type Recombinant mAb
Isotype IgG
Application WB
Reactivity Hu
Positive Sample MCF7, SH-SY5Y
Purification Protein A
Concentration 0.5 mg/ml
Conjugation Unconjugated
Physical Appearance Liquid
Storage Buffer

PBS, 40% Glycerol, 0.05% BSA, 0.02% sodium azide

Stability & Storage

12 months from date of receipt / reconstitution, -20 °C as supplied

Dilution


application dilution species
WB 1:1000 Hu

Background

BRIP1, full name BRCA1-interacting protein C-terminal helicase 1, also known as FANCJ or BACH1, is an ironsulfur clustercontaining DNA helicase encoded by the BRIP1 gene and belongs to the SF2 helicase superfamily. Its core function is to act as a key factor in DNA damage repair: it uses the energy provided by ATP hydrolysis to unwind various DNA substrates in the 5′→3′ direction, including duplex DNA, Dloops, and noncanonical secondary structures such as Gquadruplexes, which is essential for the smooth progression of replication forks and the maintenance of genomic stability. Functionally, BRIP1 serves as an important intersection between the Fanconi anemia (FA) pathway and the homologous recombination (HR) repair pathway; it directly interacts with the BRCT domain of the breast cancer susceptibility protein BRCA1 through its Cterminal phosphorylation sites, participating in the repair of DNA interstrand crosslinks and doublestrand breaks. Consequently, pathogenic variants in BRIP1 lead to severe consequences: biallelic mutations cause Fanconi anemia complementation group J, characterized by bone marrow failure, developmental abnormalities, and a strong predisposition to cancer; while monoallelic germline lossoffunction mutations or functionally impaired missense variants (BRIP1 is an ovarian cancer susceptibility gene, with approximately 75% of rare missense variants resulting in loss of function) significantly increase the risk of breast and ovarian cancers, making it of great importance in clinical oncogenetic counseling.

Picture

Western Blot

WB result of BRIP1 Recombinant Rabbit mAb
Primary antibody: BRIP1 Recombinant Rabbit mAb at 1/1000 dilution
Lane 1: 293T whole cell lysate 20 ug
Lane 2: MCF7 whole cell lysate 20 ug
Lane 3: SH-SY5Y whole cell lysate 20 ug
Low expression control: 293T whole cell lysate
Secondary antibody: Goat Anti-Rabbit IgG (H+L), HRP conjugated at 1/10000 dilution
Predicted MW: 140 kDa
Observed MW: 140 kDa